NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.

Barr Pharmaceuticals Inc. raised its buyout offer Friday for Croatian generic drug maker Pliva d.d. to $2.3 billion, topping an improved offer from Iceland’s Actavis Group HF. Subscribe to read this ...

ZAGREB, Croatia — Teva Pharmaceutical Industries is investing more than $100 million in its Croatian division for a plant that will make pills mostly for the international market. Teva subsidiary ...

Pliva d.d., one of the largest drug makers in Central and Eastern Europe, said Tuesday it had accepted a $2.2 billion cash takeover offer from U.S.-based Barr Pharmaceuticals Inc. that tops the last ...

The Croatian drugs company Pliva has started an auction of its business after rejecting a $1.6bn (£910m) offer from Iceland's Actavis, prompting speculation that there could be a round of ...

We’ll send you a myFT Daily Digest email rounding up the latest Croatia news every morning. Pliva, the Croatian generic drugmaker, on Friday judged a $2.5bn takeover bid by Actavis of Iceland “fair ...

We’ll send you a myFT Daily Digest email rounding up the latest Barr Pharms news every morning. Size is not everything – unless you are one of the players in the global generic drugs industry. Barr ...

Pliva has reported a 17% decline in first-quarter revenues as royalty income from sales of Pfizer’s antibiotic Zithromax fell through the floor, but said its generics business had a ‘strong’ quarter.

Teva Pharmaceutical Industries ($TEVA) CEO Jeremy Levin has been very frank about the need to cut costs by cutting jobs--about 5,000 jobs. But that does not mean the ...

On April 28, the US Food and Drug Administration's Center for Drug Evaluation and Research (Rockville, MD) issued a Warning Letter to Pliva Hrvatska d.o.o., a subsidiary of Pliva d.d. (Zagreb, Croatia ...

Barr Pharmaceuticals stepped up the pressure to buy Croatian generics company Pliva yesterday after filing its intentions formally with global regulators, including the US Federal Trade Commission and ...

Pliva?s new Oral Solid Forms Facility will increase Pliva's production capacities for tablets and capsules. Pliva's new oral solid forms facility at its production site in Zagreb will increase Pliva's ...